Prevalence of Dementia in the United States: The Aging, Demographics, and Memory Study
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Aim: To estimate the prevalence of Alzheimer’s disease (AD) and other dementias in the USA using a nationally representative sample. Methods: The Aging, Demographics, and Memory Study sample was composed of 856 individuals aged 71 years and older from the nationally representative Health and Retirement Study (HRS) who were evaluated for dementia using a comprehensive in-home assessment. An expert consensus panel used this information to assign a diagnosis of normal cognition, cognitive impairment but not demented, or dementia (and dementia subtype). Using sampling weights derived from the HRS, we estimated the national prevalence of dementia, AD and vascular dementia by age and gender. Results: The prevalence of dementia among individuals aged 71 and older was 13.9%, comprising about 3.4 million individuals in the USA in 2002. The corresponding values for AD were 9.7% and 2.4 million individuals. Dementia prevalence increased with age, from 5.0% of those aged 71–79 years to 37.4% of those aged 90 and older. Conclusions: Dementia prevalence estimates from this first nationally representative population-based study of dementia in the USA to include subjects from all regions of the country can provide essential information for effective planning for the impending healthcare needs of the large and increasing number of individuals at risk for dementia as our population ages.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Many studies suggest that racial and ethnic differences in dementia risk do not persist in rigorous analyses that account for health and socioeconomic factors.”
From 2023 Alzheimer's disease facts and figures (2023) · cites this paper as [316]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Many studies suggest that racial and ethnic differences in dementia risk do not persist in rigorous analyses that account for health and socioeconomic factors.”
From 2024 Alzheimer's disease facts and figures (2024) · cites this paper as [343]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“for example, EVs can induce ciliary signaling pathways and ciliogenesis, ciliary signaling can regulate vesicle release, and TNTs have been shown to transfer vesicles between cells [35,36].”
From The Impact of Neurotoxin Proteins Trafficked by Primary Cilia and Extracellular Vesicles in Neurodegenerative Diseases (2025) · cites this paper as [36]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“for example, EVs can induce ciliary signaling pathways and ciliogenesis, ciliary signaling can regulate vesicle release, and TNTs have been shown to transfer vesicles between cells [35,36].”
From The Impact of Neurotoxin Proteins Trafficked by Primary Cilia and Extracellular Vesicles in Neurodegenerative Diseases (2025) · cites this paper as [36]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“for example, EVs can induce ciliary signaling pathways and ciliogenesis, ciliary signaling can regulate vesicle release, and TNTs have been shown to transfer vesicles between cells [35,36].”
From The Impact of Neurotoxin Proteins Trafficked by Primary Cilia and Extracellular Vesicles in Neurodegenerative Diseases (2025) · cites this paper as [36]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Statistical Analysis With Missing Data
Lahiff, M., Little, R. J. A., & Rubin, D. B. (1989) · Journal of the American Statistical Association · doi:10.2307/2289883 · Cited by 17,265
Mild Cognitive Impairment: Clinical Characterization and Outcome
Petersen, R. C., Smith, G. E., Waring, S. C., Ivnik, R. J., Tangalos, E. G., & Kokmen, E. (1999) · Archives of Neurology · doi:10.1001/archneur.56.3.303 · Cited by 8,980
Statistical Analysis with Missing Data
Little, R. J. A., & Rubin, D. B. (2002) · Wiley Series in Probability and Statistics · doi:10.1002/9781119013563 · Cited by 8,473
Global prevalence of dementia: a Delphi consensus study
Ferri, C. P., Prince, M., Brayne, C., Brodaty, H., Fratiglioni, L., Ganguli, M., Hall, K., Hasegawa, K., Hendrie, H., Huang, Y., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67889-0 · Cited by 5,332 · cited 3×
“S.[3] The four previous national estimates of AD prevalence estimates differed by greater than two-fold and ranged from 2.”
BackgroundMethodRomán, G. C., Tatemichi, T. K., Erkinjuntti, T., Cummings, J. L., Masdeu, J. C., Garcia, J. H., Amaducci, L., Orgogozo, J.-M., Brun, A., Hofman, A., et al. (1993) · Neurology · doi:10.1212/wnl.43.2.250 · Cited by 4,921
McKeith, I. G., Galasko, D., Kosaka, K., Perry, E. K., Dickson, D. W., Hansen, L. A., Salmon, D. P., Lowe, J., Mirra, S. S., Byrne, E. J., et al. (1996) · Neurology · doi:10.1212/wnl.47.5.1113 · Cited by 3,960 · cited 1×
“Currently accepted diagnostic criteria for subtypes of dementia were used.[19-21, 27] DSM criteria for dementia require memory impairment, however some subtypes of dementia do not present with prominent memory problems.”
MethodAlzheimer Disease in the US Population: Prevalence Estimates Using the 2000 Census
Hebert, L. E., Scherr, P. A., Bienias, J. L., Bennett, D. A., & Evans, D. A. (2003) · Archives of Neurology · doi:10.1001/archneur.60.8.1119 · Cited by 2,168 · cited 2×
“5 million.[5,26] The lowest estimate came from a meta-analysis of 18 US and European studies; the highest from the East Boston and Chicago community studies.”
BackgroundBrookmeyer, R., Gray, S., & Kawas, C. (1998) · American Journal of Public Health · doi:10.2105/ajph.88.9.1337 · Cited by 1,787 · cited 1×
“[2-6], all employing extrapolations from a few U.”
Method
Research works printed but not linked: 6
- Evans DA, Scherr PA, Cook NR, Albert MS, Funkenstein HH, Smith LA, Hebert LE, Wetle TT, Branch LG, Chown M, Hennekens CH, Taylor JO. Estimated prevalence of Alzheimer's disease in the United States. Milbank Q. 1990;68:267–289. [PubMed] [Google Scholar]
- United States General Accounting Office . Alzheimer's Disease: Estimates of Prevalence in the United States. Washington: United States General Accounting Office; 1998. [Google Scholar]
- Willis RJ. Theory confronts data: how the HRS is shaped by the economics of aging and how the economics of aging will be shaped by the HRS. Labour Econ. 1999;6:119–145. [Google Scholar]
- American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders, ed 3, revised. Washington: American Psychiatric Association; 1987. [Google Scholar]
- Hebert LE, Scherr PA, Bienias JL, Bennett DA, Evans DA. Alzheimer disease in the US population: prevalence estimates using the 2000 census. Arch Neurol. 2003;60:1119–1122. doi: 10.1001/archneur.60.8.1119. [DOI] [PubMed] [Google Scholar] · DOI · Paper page
- 10.1001%2fjama.278.16.1349 · doi:10.1001/jama.278.16.1349 · Paper page
Cited by
Items 201–300 of 1,002
Analysis of the MIRIAD Data Shows Sex Differences in Hippocampal Atrophy Progression
Ardekani, B. A., Convit, A., & Bachman, A. H. (2016) · Journal of Alzheimer's Disease · doi:10.3233/jad-150780 · Cited by 141
Serum Albumin Concentration and Cognitive Impairment
Llewellyn, D., Langa, K., Friedland, R., & Lang, I. (2010) · Current Alzheimer Research · doi:10.2174/156720510790274392 · Cited by 138
“[1,2] Critical to translating new therapies into improved patient care is the development of costeffective panels of biomeasures that complement cognitive testing, clinical examination, and neuroimaging.”
BackgroundSelf-citationTarget Identification for CNS Diseases by Transcriptional Profiling
Altar, C. A., Vawter, M. P., & Ginsberg, S. D. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.172 · Cited by 142
“About 4.5 million Americans have AD today, and this number may reach 11–16 million by 2050 (Plassman et al, 2007; Wimo et al, 2007).”
InfluentialCorsentino, E. A., Collins, N., Sachs-Ericsson, N., & Blazer, D. G. (2009) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glp116 · Cited by 136
Williamson, V., Stevelink, S. A. M., Greenberg, K., & Greenberg, N. L. (2017) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2017.11.001 · Cited by 142
“geriatric community studies.(57) The potential moderating effect of SES was also observed, and studies with lower participant income reported higher dementia prevalence, consistent with past research that has found low SES to be a risk factor for dementia.”
ResultMcWilliams, J. M., Afendulis, C. C., McGuire, T. G., & Landon, B. E. (2011) · Health Affairs · doi:10.1377/hlthaff.2011.0132 · Cited by 146
Obstructive sleep apnea treatment and dementia risk in older adults
Dunietz, G. L., Chervin, R. D., Burke, J. F., Conceicao, A. S., & Braley, T. J. (2021) · Sleep · doi:10.1093/sleep/zsab076 · Cited by 133
“However, as the typical onset of OSA is in middle age, whereas dementia typically appears later in life, the present findings may well reflect an influence of OSA on dementia decades after its onset [33, 34].”
BackgroundSelf-citationZlatar, Z. Z., Moore, R. C., Palmer, B. W., Thompson, W. K., & Jeste, D. V. (2014) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988714524628 · Cited by 124
“When dividing our sample into those with NCI and SCI based on TICS-m scores, our rates of SCI were close to the prevalence rates of dementia reported by the Aging, Demographics, and Memory Study.(32,41) This further validates the utility of the TICS-m as a screening tool for large population-based studies of aging, wh…”
ResultGarcía, M. A., Downer, B. G., Chiu, C., Saenz, J. L., Rote, S. M., & Wong, R. (2017) · The Gerontologist · doi:10.1093/geront/gnx142 · Cited by 139
“An estimated 13.9% of adults aged 71 and older have dementia (Plassman et al., 2007) and an additional 22% have cognitive impairment that is not severe enough to warrant a diagnosis of dementia (Plassman et al., 2008).”
BackgroundInfluentialDementia, Alzheimer’s Disease, and Mortality after Hemodialysis Initiation
McAdams‐DeMarco, M., Daubresse, M., Bae, S., Gross, A. L., Carlson, M. C., & Segev, D. L. (2018) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.10150917 · Cited by 138
“Additionally, we identified black and Hispanic patients on hemodialysis as being at an elevated risk of being diagnosed with dementia, which is consistent with findings from the geriatric literature (32); these racial and ethnic differences have been attributed to the greater burden of chronic comorbidity in older adu…”
ResultWalker, J., & Harrison, F. (2015) · Nutrients · doi:10.3390/nu7095341 · Cited by 126
“AD is the most common form of dementia in older adults in the US, with vascular dementia (VaD) being the second most common [47].”
BackgroundScreening for Mild Cognitive Impairment: Comparison of “MCI Specific” Screening Instruments
Ó’Caoimh, R., Timmons, S., & Molloy, D. W. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-150881 · Cited by 137
“As society ages, the prevalence of cognitive impairment (CI) is expected to rise [1, 2], resulting in increased numbers of older people presenting with memory complaints.”
BackgroundSocial and Assistive Robotics in Dementia Care: Ethical Recommendations for Research and Practice
Ienca, M., Jotterand, F., Vică, C., & Elger, B. S. (2016) · International Journal of Social Robotics · doi:10.1007/s12369-016-0366-7 · Cited by 142
Venkat, P., Chopp, M., Zacharek, A., Cui, C., Zhang, L., Li, Q., Lu, M., Zhang, T., Liu, A., & Chen, J. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.11.002 · Cited by 128
Zhou, J. W., Peng, W., Xu, M., Li, W., & Liu, Z. (2015) · Medicine · doi:10.1097/md.0000000000000933 · Cited by 137
“Decline in cognitive functions leads to loss of independent function of patients that has an wide impact on families and healthcare systems.(3) The biggest factor of AD is aging and the population over the age of 85 years have higher frequencies of incidence(4) Moreover, female gender are also as a risk factor for AD.”
BackgroundWong, W. B., Lin, V. W., Boudreau, D., & Devine, E. B. (2013) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3381 · Cited by 124
Long-term exposure to air pollution and trajectories of cognitive decline among older adults
Kulick, E. R., Wellenius, G. A., Boehme, A. K., Joyce, N. R., Schupf, N., Kaufman, J. D., Mayeux, R., Sacco, R. L., Manly, J. J., & Elkind, M. S. V. (2020) · Neurology · doi:10.1212/wnl.0000000000009314 · Cited by 119
“5 times as likely as older non-Hispanic whites to develop incident dementia.(49,50) It is important to have a racially and ethnically diverse population of older adults that is not limited by sex to be able to ascertain differences in higher risk groups and also be able to generalize results to an aging urban populati…”
BackgroundNeurodegenerative Disorders and Sleep
Malhotra, R. K. (2018) · Sleep Medicine Clinics · doi:10.1016/j.jsmc.2017.09.006 · Cited by 127
Juan, S. M. A., & Adlard, P. A. (2019) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-981-13-3681-2_5 · Cited by 135
Rahman, M., White, E. M., Mills, C., Thomas, K. S., & Jutkowitz, E. (2021) · Alzheimer's & Dementia · doi:10.1002/alz.12285 · Cited by 119
Sex and age interact to determine clinicopathologic differences in Alzheimer’s disease
Liesinger, A. M., Graff-Radford, N. R., Duara, R., Carter, R. E., Hanna Al-Shaikh, F. S., Koga, S., Hinkle, K. M., DiLello, S. K., Johnson, M. F., Aziz, A., et al. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1908-x · Cited by 126
Rastegari, A., Nadri, H., Mahdavi, M. R., Moradi, A., Mirfazli, S. S., Edraki, N., Moghadam, F. H., Larijani, B. A., Akbarzadeh, T., & Saeedi, M. (2018) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2018.10.065 · Cited by 132
Li, H., Wang, H., Chou, F., & Chen, K. (2014) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2014.10.004 · Cited by 131
Mechanistic Link between Vitamin B12 and Alzheimer’s Disease
Lauer, A. A., Grimm, H. S., Apel, B., Golobrodska, N., Kruse, L., Ratanski, E., Schulten, N., Schwarze, L., Slawik, T., Sperlich, S., et al. (2022) · Biomolecules · doi:10.3390/biom12010129 · Cited by 138
“Alzheimer’s disease (AD) is a devastating neurodegenerative disorder and the most common form of dementia in the elderly population, clinically characterized in patients by a progressive loss of cognitive brain functions leading to memory loss and cognitive decline [1,2].”
BackgroundFisher, G. G., Franks, M. M., Plassman, B. L., Brown, S. L., Potter, G. G., Llewellyn, D., Rogers, M. A. M., & Langa, K. M. (2011) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2010.03304.x · Cited by 123
“Key words: caregiving; mild cognitive impairment; dementia; aging Dementia affects a large and growing number of indi-viduals and families in the United States.1,2 Informal caregivers spend significant time caring for those with dementia,3 which may allow those with dementia to remain at home longer and delay the need…”
InfluentialSelf-citationMalinowsky, C., Almkvist, O., Kottorp, A., & Nygård, L. (2010) · Disability and Rehabilitation: Assistive Technology · doi:10.3109/17483107.2010.496098 · Cited by 123
Neurodegenerative diseases and therapeutic strategies using iron chelators
Ward, R. J., Dexter, D. T., & Crichton, R. R. (2015) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2014.12.012 · Cited by 134
“4% of those aged 90 and older [2].”
BackgroundKulick, E. R., Elkind, M. S. V., Boehme, A. K., Joyce, N. R., Schupf, N., Kaufman, J. D., Mayeux, R. P., Manly, J. J., & Wellenius, G. A. (2020) · Environment International · doi:10.1016/j.envint.2019.105440 · Cited by 133
Screening for Cognitive Impairment: Comparing the Performance of Four Instruments in Primary Care
Holsinger, T., Plassman, B. L., Stechuchak, K. M., Burke, J. R., Coffman, C. J., & Williams, J. W. (2012) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2012.03967.x · Cited by 118
“In a nationwide population-based study, approximately 14% of older adults aged 70 and older had dementia.(1) In primary care, between 10% and 15% of older adults have evidence of cognitive impairment.”
BackgroundSelf-citationPreoperative assessment of the older surgical patient: honing in on geriatric syndromes
Groban, L., Kim, S., & Brooks, A. K. (2014) · Clinical Interventions in Aging · doi:10.2147/cia.s75285 · Cited by 144
Racial Differences in Knowledge and Beliefs About Alzheimer Disease
Connell, C. M., Scott Roberts, J., McLaughlin, S. J., & Akinleye, D. (2009) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e318192e94d · Cited by 113
“Alzheimer disease (AD) is an increasingly significant public health issue with more than 2 million older adults estimated to be affected nationwide.(1) With the aging of our population, an estimated 10 million US baby boomers are predicted to develop the disease in the coming decades.”
BackgroundTrammell, J. P., MacRae, P. G., Davis, G. L., Bergstedt, D., & Anderson, A. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00364 · Cited by 125
“, 2013)—increases from 1 in 20 persons for those 71–79 years of age, to 1 in 3 persons for those over 90 years of age (Plassman et al., 2007).”
BackgroundMcGrath, R. P., Johnson, N., Klawitter, L. A., Mahoney, S. J., Trautman, K. A., Carlson, C. M., Rockstad, E., & Hackney, K. J. (2020) · SAGE Open Medicine · doi:10.1177/2050312120910358 · Cited by 135
Alzheimer's disease and automatic speech analysis: A review
Pulido, M. L. B., Hernández, J. B. A., Ballester, M. Á. F., González, C. M. T., Mekyska, J., & Smékal, Z. (2020) · Expert Systems with Applications · doi:10.1016/j.eswa.2020.113213 · Cited by 120
Innes, A., Page, S. J., & Cutler, C. (2015) · Dementia · doi:10.1177/1471301215570346 · Cited by 120
“…as ‘Dementia is a disease of particular concern because the decline in memory and other cognitive functions that characterizes this condition also leads to a loss of independent function that has a wideranging impact on individuals, families and healthcare systems’ (Plassman et al., 2007, p. 125).”
BackgroundFactors associated with cognitive evaluations in the United States
Kotagal, V., Langa, K. M., Plassman, B. L., Fisher, G. G., Giordani, B. J., Wallace, R. B., Burke, J. R., Steffens, D. C., Kabeto, M., Albin, R. L., et al. (2015) · Neurology · doi:10.1212/wnl.0000000000001096 · Cited by 119
“More than 1 in 8 individuals in the United States over the age of 65 years has dementia.(1) Only a fraction of these individuals, however, receive a clinical evaluation for cognitive concerns.”
BackgroundSelf-citationAlternative splicing of mRNA in the molecular pathology of neurodegenerative diseases
Mills, J. D., & Janitz, M. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.10.030 · Cited by 136
“It is almost certain that age plays a role in a patient’s susceptibility to AD, as the prevalence increases from 1% for individuals between 60 and 64 years of age (Jorm et al., 2005; Lobo et al., 2000; Plassman et al., 2007) to 40–70% for individuals older than 90 years of age (Fratiglioni et al.”
BackgroundTourism as a dementia treatment based on positive psychology
Wen, J., Zheng, D., Hou, H., Phau, I., & Wang, W. (2022) · Tourism Management · doi:10.1016/j.tourman.2022.104556 · Cited by 131
Shen, L., & Ji, H. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150140 · Cited by 133
“With the accelerating population aging process the prevalence of AD is rising steadily [1, 2].”
Exogenous Hsp70 delays senescence and improves cognitive function in aging mice
Bobkova, N. V., Evgen’ev, M., Garbuz, D. G., Kulikov, A. M., Morozov, A., Samokhin, A., Velmeshev, D., Medvinskaya, N., Nesterova, I., Pollock, A., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1516131112 · Cited by 118
“This finding confirms the results of many studies demonstrating cognitive decline in the elderly (26, 27).”
ResultAssessment Tools Predicting Fitness to Drive in Older Adults: A Systematic Review
Dickerson, A. E., Meuel, D. B., Ridenour, C. D., & Cooper, K. (2014) · American Journal of Occupational Therapy · doi:10.5014/ajot.2014.011833 · Cited by 128
Hshieh, T. T., Jung, W. F., Grande, L. J., Chen, J., Stone, R. M., Soiffer, R. J., Driver, J. A., & Abel, G. A. (2018) · JAMA Oncology · doi:10.1001/jamaoncol.2017.5674 · Cited by 117
Dementia and mild cognitive impairment in adults with intellectual disability: Issues of diagnosis
Krinsky‐McHale, S. J., & Silverman, W. (2013) · Developmental Disabilities Research Reviews · doi:10.1002/ddrr.1126 · Cited by 108
“Alzheimer’s disease has become a major public health concern, accounting for an estimated 60 to 80% of all cases of dementia [Alzheimer’s Association, 2012] and affecting approximately 2.4 million individuals in the United States alone [Plassman et al., 2007].”
InfluentialKuller, L. H., Lopez, O. L., Mackey, R. H., Rosano, C., Edmundowicz, D., Becker, J. T., & Newman, A. B. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.12.034 · Cited by 114
“White men 5 (6) 12 (16) 18 (23) 42 (55) Black men 10 (34) 5 (17) 5 (17) 9 (32) <0.”
Rao, A. K., Chou, A., Bursley, B., Smulofsky, J., & Jezequel, J. (2014) · The American Journal of Occupational Therapy · doi:10.5014/ajot.2014.009035 · Cited by 107
“An estimated 5.4 million Americans, nearly two-thirds of whom are women, have been diagnosed with AD (Hebert, Scherr, Bienias, Bennett, & Evans, 2003; Plassman et al., 2007; Seshadri et al., 1997).”
InfluentialBrain iron accumulation in aging and neurodegenerative disorders
Hagemeier, J., Geurts, J. J. G., & Zivadinov, R. (2012) · Expert Review of Neurotherapeutics · doi:10.1586/ern.12.128 · Cited by 121
The Impact of Vitamin E and Other Fat-Soluble Vitamins on Alzheimer´s Disease
Grimm, M. O. W., Mett, J., & Hartmann, T. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17111785 · Cited by 126
Dhahbi, W., Briki, W., Heißel, A., Schega, L., Dergaa, I., Guelmami, N., Omri, A. E., & Chaabène, H. (2025) · Sports Medicine - Open · doi:10.1186/s40798-025-00857-2 · Cited by 121
“Second, while we aimed to focus on cognitively healthy older adults, the definition of "cognitive health" varied across studies [16, 25].”
Cognability: An Ecological Theory of neighborhoods and cognitive aging
Finlay, J., Esposito, M. H., Langa, K. M., Judd, S. E., & Clarke, P. J. (2022) · Social Science & Medicine · doi:10.1016/j.socscimed.2022.115220 · Cited by 113
Self-citationThe Six Dimensions of Wellness and Cognition in Aging Adults
Strout, K. A., & Howard, E. (2012) · Journal of Holistic Nursing · doi:10.1177/0898010112440883 · Cited by 131
“Specifically, 12 or more years of formal education compared with fewer than 12 years of education correlates with stronger cognitive performance in older age (Koster et al., 2005; Lièvre, Alley, & Crimmins, 2008; Plassman et al., 2007).”
BackgroundInfluentialToxin-Induced Experimental Models of Learning and Memory Impairment
More, S. V., Kumar, H., Cho, D.-Y., Yun, Y.-S., & Choi, D. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17091447 · Cited by 120
“A study document from demographics of aging and memory [7], anticipated that in America the number of people with dementia was 4.”
BackgroundGodfrey, M., & Lee, N. R. (2018) · Journal of Neurodevelopmental Disorders · doi:10.1186/s11689-017-9220-y · Cited by 89
Evaluation of Medicare Claims Data as a Tool to Identify Dementia
Lee, E., Gatz, M., Tseng, C., Schneider, L. S., Pawluczyk, S., Wu, A. H., & Deapen, D. (2019) · Journal of Alzheimer’s Disease · doi:10.3233/jad-181005 · Cited by 102
Prevalence of Cognitive Impairment in Older Adults with Heart Failure
Gure, T. R., Blaum, C. S., Giordani, B., Koelling, T. M., Gałecki, A. T., Pressler, S. J., Hummel, S. L., & Langa, K. M. (2012) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2012.04097.x · Cited by 116
Self-citationNicholas, L. H., Bynum, J. P. W., Iwashyna, T. J., Weir, D. R., & Langa, K. M. (2014) · Health Affairs · doi:10.1377/hlthaff.2013.1258 · Cited by 104
Self-citationA Primary Care Agenda for Brain Health: A Scientific Statement From the American Heart Association
Lazar, R. M., Howard, V. J., Kernan, W. N., Aparicio, H. J., Levine, D. A., Viera, A. J., Jordan, L. C., Nyenhuis, D. L., Possin, K. L., Sorond, F. A., et al. (2021) · Stroke · doi:10.1161/str.0000000000000367 · Cited by 109
Cho, H. K. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00279 · Cited by 142
Assessment of cognition in early dementia
Silverberg, N. B., Ryan, L. M., Carrillo, M. C., Sperling, R., Petersen, R. C., Posner, H. B., Snyder, P. J., Hilsabeck, R., Gallagher, M., Raber, J., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.05.001 · Cited by 93
“Although Hispanics have the greatest life expectancy among all minority groups, they also have a higher prevalence of medical conditions that are associated with cognitive impairment, including vascular pathology, hypertension, and diabetes [86,87].”
BackgroundCombining Direct and Proxy Assessments to Reduce Attrition Bias in a Longitudinal Study
Wu, Q., Tchetgen Tchetgen, E. J., Osypuk, T. L., White, K., Mujahid, M., & Maria Glymour, M. (2013) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e31826cfe90 · Cited by 102
Nutrient intake, nutritional status, and cognitive function with aging
Tucker, K. L. (2016) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13062 · Cited by 117
Cardiac Disorders as Risk Factors for Alzheimer's Disease
de Toledo Ferraz Alves, T. C., Ferreira, L. K., Wajngarten, M., & Busatto, G. F. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-091561 · Cited by 102
“Alzheimer’s disease (AD) and vascular dementia (VaD) are the leading causes of dementia [1–3].”
Trends in the Prevalence of Dementia in Japan
Dodge, H. H., Buracchio, T. J., Fisher, G. G., Kiyohara, Y., Meguro, K., Tanizaki, Y., & Kaye, J. A. (2012) · International Journal of Alzheimer's Disease · doi:10.1155/2012/956354 · Cited by 98
“In the Aging, Demographics, and Memory Study (ADAMS) [36, 37], which is the first study in the US to calculate a nationally representative dementia prevalence, the agespecific AD/VaD ratios were found to be 2.”
InfluentialSelf-citationPlasma 24-metabolite Panel Predicts Preclinical Transition to Clinical Stages of Alzheimer’s Disease
Fiandaca, M. S., Zhong, X., Cheema, A. K., Orquiza, M. H., Chidambaram, S., Tan, M. T., Gresenz, C. R., FitzGerald, K. T., Nalls, M. A., Singleton, A. B., et al. (2015) · Frontiers in Neurology · doi:10.3389/fneur.2015.00237 · Cited by 109
Frith, E., Shivappa, N., Mann, J. R., Hébert, J. R., Wirth, M. D., & Loprinzi, P. D. (2018) · British Journal of Nutrition · doi:10.1017/s0007114517003804 · Cited by 106
Thomas, K. S., Baier, R. R., Kosar, C. M., Ogarek, J. A., Trepman, A. Z., & Mor, V. (2017) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2017.04.008 · Cited by 116
Vascular dementia: From pathobiology to emerging perspectives
Morgan, A. E., & Auley, M. T. M. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102278 · Cited by 116
“After Alzheimer ’ s disease (AD), vascular dementia (VaD) is recognised as the second most common type of dementia, accounting for approximately 20% of all dementia cases (Akhter et al., 2021; Plassman et al., 2007).”
BackgroundRate of cognitive decline in relation to sex after 60 years‐of‐age: A systematic review
Ferreira, L., Ferreira Santos‐Galduróz, R., Ferri, C. P., & Fernandes Galduróz, J. C. (2014) · Geriatrics & Gerontology International · doi:10.1111/ggi.12093 · Cited by 101
Gamble, J. L., Balbus, J. M., Berger, M., Bouye, K. E., Campbell, V., Chief, K., Conlon, K. C., Crimmins, A. R., Flanagan, B. E., Gonzalez-Maddux, C., et al. (2016) · doi:10.7930/j0q81b0t · Cited by 150
Hunt, L. J., Covinsky, K. E., Yaffe, K. S., Stephens, C. E., Miao, Y., Boscardin, W. J., & Smith, A. (2015) · Journal of the American Geriatrics Society · doi:10.1111/jgs.13536 · Cited by 112
“The NHATS algorithm results in population-based estimates of dementia that are similar to those found in other major population-based studies.(1,36) The NHATS dementia algorithm was further modified to ensure that the current study sample met nationally recognized diagnostic criteria for dementia.”
ResultAPP Function and Lipids: A Bidirectional Link
Grimm, M. O. W., Mett, J., Grimm, H. S., & Hartmann, T. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00063 · Cited by 104
“Clinically AD is characterized by a progressive loss of cognitive brain functions leading to memory dysfunction, impaired judgment, disorientation and finally to a total loss of memory and personality (Plassman et al., 2007; World Alzheimer Report, 2015).”
BackgroundAfrican Americans are less likely to enroll in preclinical Alzheimer's disease clinical trials
Zhou, Y., Elashoff, D., Kremen, S., Teng, E., Karlawish, J., & Grill, J. D. (2017) · Alzheimer's & Dementia: Translational Research & Clinical Interventions · doi:10.1016/j.trci.2016.09.004 · Cited by 95
Association of orthostatic hypotension with incident dementia, stroke, and cognitive decline
Rawlings, A. M., Juraschek, S. P., HEISS, G. M., Hughes, T. M., Meyer, M. L., Selvin, E., Sharrett, A. R., Windham, B. G., & Gottesman, R. F. (2018) · Neurology · doi:10.1212/wnl.0000000000006027 · Cited by 105
Animal models of dementia and cognitive dysfunction
Neha, N., Sodhi, R. K., Jaggi, A. S., & Singh, N. (2014) · Life Sciences · doi:10.1016/j.lfs.2014.05.017 · Cited by 110
Military Risk Factors for Cognitive Decline, Dementia and Alzheimer’s Disease
Veitch, D., Friedl, K., & Weiner, M. (2013) · Current Alzheimer Research · doi:10.2174/15672050113109990142 · Cited by 103
McLaren, A. N., LaMantia, M. A., & Callahan, C. M. (2013) · Aging & Mental Health · doi:10.1080/13607863.2013.781121 · Cited by 103
“8 million Americans suffer from dementia and 60–80% of these cases are believed to be due to Alzheimer’s disease (Plassman, 2007).”
InfluentialCognition and Cognitive Impairment in Older Adults with Cancer
Magnuson, A. M., Mohile, S. G., & Janelsins, M. C. (2016) · Current Geriatrics Reports · doi:10.1007/s13670-016-0182-9 · Cited by 109
Liao, X., Li, G., Wang, A., Liu, T., Feng, S., Guo, Z., Tang, Q., Jin, Y., Xing, G., McClure, M. A., et al. (2015) · Journal of Alzheimer's Disease · doi:10.3233/jad-150346 · Cited by 99
“mon in elderly people [1], accounting for 80% of”
Longitudinal Research on Aging Drivers (LongROAD): study design and methods
Li, G., Eby, D. W., Santos, R. G., Mielenz, T. J., Molnar, L. J., Strogatz, D. S., Betz, M. E., DiGuiseppi, C. G., Ryan, L. H., Jones, V., et al. (2017) · Injury Epidemiology · doi:10.1186/s40621-017-0121-z · Cited by 105
“Many of these potentially-impairing medical conditions are common; about one quarter of adults age 80 years and older have uncorrectable visual impairment (Congdon et al. 2004) and 35% of adults age 85 years and older have some form of dementia (Plassman et al. 2007).”
BackgroundPoon, L. W., Martin, P., Bishop, A. J., Cho, J., da Rosa, G., Deshpande, N. A., Hensley, R. B., MacDonald, M. M., Margrett, J. A., Randall, G. K., et al. (2010) · Current Gerontology and Geriatrics Research · doi:10.1155/2010/680657 · Cited by 109
“The possible prevalence approaches 80% among centenarians [56, 61, 62].”
BackgroundMishra, S., Beheshti, I., & Khanna, P. (2021) · IEEE Reviews in Biomedical Engineering · doi:10.1109/rbme.2021.3107372 · Cited by 108
“and perform meditation regularly show a reduction in the brain aging process [27], [28].”
BackgroundDepression in Cognitive Impairment
Pellegrino, L. D., Peters, M. E., Lyketsos, C. G., & Marano, C. M. (2013) · Current Psychiatry Reports · doi:10.1007/s11920-013-0384-1 · Cited by 116
“4 million individuals in the United States [3].”
InfluentialHormone Replacement Therapy and Risk for Neurodegenerative Diseases
Dye, R. V., Miller, K. J., Singer, E. J., & Levine, A. J. (2012) · International Journal of Alzheimer's Disease · doi:10.1155/2012/258454 · Cited by 95
“Alzheimer’s disease (AD) represents the most common neurodegenerative disease, accounting for more than 50% of all dementia types [1].”
BackgroundInfluentialTari, A. R., Nauman, J., Zisko, N., Skjellegrind, H. K., Bosnes, I., Bergh, S., Stensvold, D., Selbæk, G., & Wisløff, U. (2019) · The Lancet Public Health · doi:10.1016/s2468-2667(19)30183-5 · Cited by 100
Poey, J. L., Burr, J. A., & Roberts, J. S. (2017) · The Gerontologist · doi:10.1093/geront/gnw154 · Cited by 89
Luo, X., Li, A., Yang, X., Xiao, X., Hu, R. H., Wang, T., Dou, X., Yang, D., & Dong, Z. (2018) · Chinese Medicine · doi:10.1186/s13020-018-0173-1 · Cited by 103
Trajectory of Mobility Decline by Type of Dementia
Tolea, M. I., Morris, J. C., & Galvin, J. E. (2016) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000091 · Cited by 90
Hudomiet, P., Hurd, M. D., & Rohwedder, S. (2018) · The Journals of Gerontology: Series B · doi:10.1093/geronb/gbx169 · Cited by 96
Self-citationIs Vasomotion in Cerebral Arteries Impaired in Alzheimer’s Disease?
Di Marco, L. Y., Farkas, E., Martin, C., Venneri, A., & Frangi, A. F. (2015) · Journal of Alzheimer's Disease · doi:10.3233/jad-142976 · Cited by 95
“Alzheimer’s disease (AD) is the most prevalent cause of dementia in the older population accounting for 65–70% of the cases [18–20].”
BackgroundImpact of Dementia on Hospitalization
Guijarro, R., San Román, C. M., Gómez-Huelgas, R., Villalobos, A., Martín, M., Guil, M., Martínez-González, M.-Á., & Toledo, J. B. (2010) · Neuroepidemiology · doi:10.1159/000311032 · Cited by 96
Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans
Mez, J., Chung, J., Jun, G., Kriegel, J., Bourlas, A. P., Sherva, R., Logue, M. W., Barnes, L. L., Bennett, D. A., Buxbaum, J. D., et al. (2017) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.09.002 · Cited by 96
(2020) · Handbook of Clinical Neurology · doi:10.1016/b978-0-444-64123-6.00018-7 · Cited by 89
Cerebrolysin for vascular dementia
Chen, N., Yang, M., Guo, J., Zhou, M., Zhu, C., & He, L. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008900.pub2 · Cited by 90
(2011) · Longitudinal and Life Course Studies · doi:10.14301/llcs.v2i2.116 · Cited by 86
“Cognitive abilities decline with age generally, and serious impairments and dementia rise sharply in prevalence with age (Brayne et al 1999; McArdle, Fisher and Kadlec 2007; Plassman et al 2007).”
BackgroundSelf-citationAnimal Toxins as Therapeutic Tools to Treat Neurodegenerative Diseases
de Souza, J. M., Gonçalves, B. D. C., Gomez, M. V., Vieira, L. B., & Ribeiro, F. M. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00145 · Cited by 101
“AD is the cause of 60–80% of dementia cases and mostly affects people over 65 years of age, leading to death in about 7–10 years of symptoms onset (Plassman et al., 2007).”
BackgroundComparative Review of the Socioeconomic Burden of Lower Back Pain in the United States and Globally
Chang, D., Lui, A., Matsoyan, A., Safaee, M., Aryan, H. E., & Ames, C. P. (2024) · Neurospine · doi:10.14245/ns.2448372.186 · Cited by 101
Agnew-Blais, J. C., Wassertheil-Smoller, S., Kang, J. H., Hogan, P. E., Coker, L. H., Snetselaar, L. G., & Smoller, J. W. (2015) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2014.07.006 · Cited by 95
Andrade, C., & Radhakrishnan, R. (2009) · Indian Journal of Psychiatry · doi:10.4103/0019-5545.44900 · Cited by 89
“9% among individuals aged 71 years and older.[3] Alzheimer's disease (AD) accounted for 69.”
Cognitive Impairment and Dementia in Elderly People Living in Rural Benin, West Africa
Guerchet, M., Houinato, D., Paraiso, M. N., von Ahsen, N., Nubukpo, P., Otto, M., Clément, J.-P., Preux, P.-M., & Dartigues, J.-F. (2009) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000188661 · Cited by 84
“while in developed countries, the prevalence of dementia reaches 12.6p in the USA among individuals aged 71 and older [”
BackgroundZarriello, S., Tuazon, J. P., Corey, S., Schimmel, S. J., Rajani, M., Gorsky, A., Abraham, D. I., Hammock, B. D., & Borlongan, C. V. (2018) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2018.11.001 · Cited by 94
“An estimated 13.9% of people over the age of 71 suffer from the cognitive decline, making it a major public health concern (Plassman et al., 2007).”
InfluentialSaur, N. M., Davis, B. R., Montroni, I., Shahrokni, A., Rostoft, S., Russell, M. M., Mohile, S. G., Suwanabol, P. A., Lightner, A. L., Poylin, V. Y., et al. (2022) · Diseases of the Colon & Rectum · doi:10.1097/dcr.0000000000002410 · Cited by 100
Metadata
- Authors
- Plassman, B. L., Langa, K. M., Fisher, G. G., Heeringa, S. G., Weir, D. R., Ofstedal, M. B., Burke, J. R., Hurd, M. D., Potter, G. G., Rodgers, W. L., Steffens, D. C., Willis, R. J., & Wallace, R. B.
- Affiliations
- Duke University (US)
- University of Michigan (US)
- Duke Medical Center (US)
- RAND Corporation (US)
- University of Iowa (US)
- ORCID
- Venue
- Neuroepidemiology
- Publisher
- S. Karger AG
- Published
- 2007
- Volume
- 29
- Issue
- 1-2
- Pages
- 125-132
- ISSN
- 0251-5350 (ISSN-L)
- 1423-0208
- PMC
- PMC2705925
- OpenAlex
- W2133488570
- Cited by
- 1,932
- References
- 44
- Citations by year
- 2026: 36 · 2025: 77 · 2024: 68 · 2023: 76 · 2022: 109 · 2021: 144 · 2020: 152 · 2019: 108 · 2018: 107 · 2017: 111 · 2016: 122 · 2015: 123 · 2014: 153 · 2013: 126 · 2012: 121
- FWCI
- 38.35
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
- Locations
- Neuroepidemiology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Aging (K08AG019180, U01 AG 09740, U01AG009740)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Keywords
- dementia prevalence, Alzheimer's disease, vascular dementia, older adults, cognitive impairment, age differences, sex differences, population aging, health planning
- MeSH terms
- Aged, Aged, 80 and over, Dementia, Female, Health Surveys, Humans, Male, United States, Cohort Studies, Geriatric Assessment, Prevalence, Logistic Models, Age Distribution, Sex Distribution
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.